Cargando…
A nanobody targeting carcinoembryonic antigen as a promising molecular probe for non-small cell lung cancer
Carcinoembryonic antigen (CEA) is a biomarker and therapy target for non-small cell lung cancer (NSCLC), which is the most common type of lung cancer. Nanobodies with high target specificity are promising candidates to function as anti-CEA probes. In the present study, the targeting effects of an an...
Autores principales: | , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
D.A. Spandidos
2017
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5482067/ https://www.ncbi.nlm.nih.gov/pubmed/28586008 http://dx.doi.org/10.3892/mmr.2017.6677 |